Defendant Name:
Howard B. Schiller
Defendant Type:
Individual
Initial Case Details
Legal Case Name
In the Matter of Howard B. Schiller
First Document Date
31-Jul-2020
Initial Filing Format
Administrative Action
File Number
3-19901
Allegation Type
Issuer Reporting and Disclosure
Affiliations
- Former: Director—Other at Valeant Pharmaceuticals International, Inc. (September 2012—June 2016)
- Former: Executive Vice President at Valeant Pharmaceuticals International, Inc. (December 2011—June 30, 2015)
- Former: CFO at Valeant Pharmaceuticals International, Inc. (December 2011—June 30, 2015)
Violations Alleged
•
Sec 304(a) Sarbanes-Oxley Act
Related Violations Alleged
Howard B. Schiller is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 12b-20 of the Exchange Act.
Howard B. Schiller is alleged to have caused Bausch Health Companies, Inc.'s violation of Sec 13(a) of the Exchange Act.
Howard B. Schiller is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 13a-1 of the Exchange Act.
Howard B. Schiller is alleged to have caused Bausch Health Companies, Inc.'s violation of Rule 13a-13 of the Exchange Act.
Howard B. Schiller is alleged to have caused Bausch Health Companies, Inc.'s violation of Sec 13(b)(2)(B) of the Exchange Act.
Resolutions
First Resolution Date
31-Jul-2020
Headline Total Penalty and Disgorgement
$100,000
